Blockchain Registration Transaction Record
NRx Pharmaceuticals Seeks FDA Approval for Preservative-Free Ketamine Amid Shortage
NRx Pharmaceuticals files for FDA approval of NRX-100, a preservative-free ketamine, addressing U.S. shortage and enhancing drug safety. Learn more about this breakthrough.

This news is crucial as it highlights a potential solution to the severe ketamine shortage in the U.S., affecting anesthesia and pain management treatments. NRx Pharmaceuticals' preservative-free formulation could improve patient safety by eliminating toxic preservatives, aligning with health initiatives. The company's efforts may expedite access to essential medications, benefiting healthcare providers and patients alike.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0x698972c931accf1cd724784d2134d7a8f01c3d75def3ee7ace916d0b80717de1 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | mint_AjX-d8173907ecbcf4ba5909372eb7db4545 |